Message from Dr. Erol Veznedaroglu
Director, Capital Institute for Neurosciences
Chair, Department of Neurosurgery
Spring is here and with it our fifth annual Neurosciences Conference. Our first conference was put together just a few months after I, along with Dr. Ken Liebman, came to Capital Health to create the Capital Institute for Neurosciences. We had close to 100 attendees at a local Princeton hotel. The conference quickly became popular, so we've had to change to larger venues in New Jersey.
This year, at Atlantic City's Revel Resort, we expect 500 health care professionals from throughout the Northeast to attend — all with an interest in advancing neurosciences treatment, research and education. Our speakers are experts in their fields from around the country. We've expanded our agenda to include all areas of neurosciences: pain management, tumors, concussions, rehabilitation and, of course, neurovascular. Our mission is to work together to bring the best care to every patient.
This year, I am excited that we are repeating our very successful community event, which is open to the public. Called “Brain Matters,” members of the public can join us in an open forum to learn from, and ask questions of, our panel of medical experts. Participants also will be able to obtain free health screenings. Last year, participants asked us about stroke care, aneurysms, headache and how to understand their own risk for neurologic problems. There's more information about the community event in this e-newsletter and at capitalneuro.org.
This year, our keynote speaker is former Speaker of the House and Time magazine Man of the Year, Newt Gingrich. Mr. Gingrich is not speaking on politics, but rather on health care. His message is that technology will drive the future of health care. I couldn't agree more. We must insure that our nation's quest for the best medical care becomes refocused on novel treatments and procedures and does not get hampered by politics and bureaucracy.
At the Capital Institute of Neurosciences, we pride ourselves for being first in the nation – and the world - to find novel therapies to fight neurological diseases and save lives. I am thrilled to announce that this fall we will be starting a trial of a novel new treatment for aneurysms that we invented in Europe. The first procedure in a human is scheduled for September. This life-saving interventional device will then be introduced here in the United States, more than likely right here in New Jersey. I look forward to updating you on all of our Institute’s new developments in the months to come. Happy Spring!